2,281 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Acquired by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,281 shares of the company’s stock, valued at approximately $207,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Rise Advisors LLC raised its position in shares of GE HealthCare Technologies by 241.4% in the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares in the last quarter. Riverview Trust Co acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $31,000. Annapolis Financial Services LLC raised its position in shares of GE HealthCare Technologies by 171.9% in the 1st quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock valued at $32,000 after purchasing an additional 220 shares in the last quarter. First Command Advisory Services Inc. raised its position in shares of GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after purchasing an additional 369 shares in the last quarter. Finally, Fortitude Family Office LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $29,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

GEHC traded down $1.32 during trading on Wednesday, reaching $80.62. 1,632,934 shares of the company were exchanged, compared to its average volume of 3,256,683. The stock has a market cap of $36.80 billion, a P/E ratio of 23.57, a PEG ratio of 2.94 and a beta of 1.26. The firm has a 50 day moving average of $85.49 and a 200 day moving average of $80.42. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting analysts’ consensus estimates of $0.90. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm’s revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.85 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were given a dividend of $0.03 per share. The ex-dividend date was Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on GEHC. HSBC began coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Evercore ISI boosted their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Citigroup boosted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price target for the company from $66.00 to $88.00 in a report on Monday, February 12th. Finally, Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.80.

Get Our Latest Stock Report on GE HealthCare Technologies

Insiders Place Their Bets

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction on Wednesday, May 1st. The stock was bought at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction on Wednesday, May 1st. The stock was bought at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total value of $5,459,510.70. Following the completion of the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,165,395.92. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Recommended Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.